On Wednesday, June 24, 2026, the Forum for Collaborative Research convened its 1st ACLF Forum as an online Zoom webinar.

Materials

Agenda
Participant List

Introductory Remarks and Program Overview

Welcome, Program Overview, and Acknowledgments
Meghan Rakowski, Forum for Collaborative Research
Veronica Miller, Forum for Collaborative Research
Richard Moreau, EF CLIF
Jacqueline O'Leary, Dallas VA Medical Center

Topic 1: Oncology and ACLF Parallels and Rationale

Why ACLF Drug Development is Unique - Clinician Perspectives
Jacqueline O'Leary, Dallas VA Medical Center

Why ACLF Drug Development is Unique - Industry Perspectives
Pejvack Motlagh, GENFIT

Topic II: Early Clinical Development Overview

Early Phase Studies in ACLF: Challenges in Recruitment and Assessment
Cornelius Engelmann, Charité – Universitätsmedizin Berlin
Dominique Thabut, AP-HP Sorbonne Université
Thomas Berg, Leipzig University Medical Center

Phase 1 Oncology Trials
Scott Berry, Berry Consultants

Utilizing Randomization, Backfill and Expansion Cohorts to Gain Greater Understanding in Phase 1 Trials
Alexia lasonos, Memorial Sloan Kettering Cancer Center

Q&A
All Participants

Topic III: Open Discussion

What Does and Does Not Transfer to ACLF
All Participants

Where to Start
All Participants

Wrap-Up

Closing Remarks
Veronica Miller, Forum for Collaborative Research
Richard Moreau, EF CLIF
Jacqueline O'Leary, Dallas VA Medical Center